Lupron depot 11.25 MG 3MO kits
Ended Awarded Last action
- Contract number
- SPE2DR26F0A8X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,643
Award facts
- Contract value 100% obligated
- $28,643.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,643.20 by the Defense Logistics Agency on January 29, 2026, for the supply of Lupron Depot 11.25 mg 3-month kits with a completion date of January 30, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical supplier to federal military healthcare systems. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order exemplifies the Defense Logistics Agency Medical Supply Chain's procurement approach for specialized pharmaceutical products required by military treatment facilities and federal healthcare systems. Lupron Depot is a hormone therapy medication used in oncology and other medical treatments, demonstrating the breadth of therapeutic domains covered under the parent IDC. AmerisourceBergen's proven capability to fulfill federal medical supply requirements through open competition, combined with its extensive portfolio across multiple drug categories and significant contract value history, positions it as a cornerstone vendor in the federal pharmaceutical distribution network serving the Department of Defense and related federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F0A8X?
SPE2DR26F0A8X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F0A8X worth?
The government has obligated $28,643 on SPE2DR26F0A8X.
Is contract SPE2DR26F0A8X an order under another contract?
Yes. SPE2DR26F0A8X is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A8X competed?
The extent of competition for SPE2DR26F0A8X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award